title: Dual response of animals with chronic cyclosporine nephrotoxicity to an acute ischemic injury.
abstract: Normal kidneys regenerate after acute injury with little development of chronic fibrosis. However, the long-term effects of an acute injury in kidneys with established chronic toxicity induced by cyclosporine (CsA) are not entirely clear. To study the consequences of an ischemia and reperfusion (IR) injury in long-term CsA-treated rats, male Wistar rats (250-300 g) were treated daily with CsA (10 mg/kg) or vehicle (olive oil 1 mL/kg) for 28 days. On day 21, ischemia was performed by clamping the renal vessel for 1 hour. Blood samples were collected on days 0 and 21 (before IR) as well as days 22 and 28. On day 28, the kidneys were collected to examine the mRNA expression of MCP-1 by real-time PCR. For renal function, serum creatinine levels were measured. Twenty-four hours after reperfusion, long-term CsA-treated animals showed better renal function compared with the control group, as demonstrated by serum creatinine levels: 2.2 +/- 0.13 mg/dL vs 2.9 +/- 0.18 mg/dL, respectively (P < .05). However, 1 week after IR, the renal function was worse among the long-term CsA-treated group than the controls: 1.16 +/- 0.08 mg/dL vs 0.8 +/- 0.09 mg/dL, respectively (P < .05). Interestingly, CsA treatment was associated with lower MCP-1 mRNA expression than that in the control group: mean MCP-1 mRNA expression 0.58 +/- 0.13 vs 1.02 +/- 0.12, respectively (P < .05). In conclusion, animals with chronic CsA nephrotoxicity were protected from an acute renal injury, possibly through decreased chemokine production, although at later time points, renal function was clearly impaired, probably by the acceleration of vasculopathy caused by nephrotoxicity.
authors.affiliation: Division of Nephrology, Federal University of São Paulo, São Paulo, Brazil.
authors.forename: G
authors.initials: G
authors.lastname: Campanholle
authors.forename: M
authors.initials: M
authors.lastname: Galvão-Pereira
authors.forename: M A
authors.initials: MA
authors.lastname: Cenedeze
authors.forename: V
authors.initials: V
authors.lastname: de Paula A Teixeira
authors.forename: M A
authors.initials: MA
authors.lastname: dos Reis
authors.forename: N O S
authors.initials: NO
authors.lastname: Camara
authors.forename: A
authors.initials: A
authors.lastname: Pacheco-Silva
mesh_terms: D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D012079:Renal Circulation / Q000187:drug effects*; D015427:Reperfusion Injury / Q000473:pathology*
chemical_list: D016572:Cyclosporine